Evaluation of prognostic factors for advanced ovarian cancer treatment with an emphasis on optimal primary cytoreduction

被引:0
作者
Vrhkar, Natasa [1 ]
Vakselj, Ales [1 ]
Verdenik, Ivan [1 ]
Smrkolj, Spela [1 ]
Barbic, Matija [1 ]
Cvjeticanin, Branko [1 ]
Meglic, Leon [1 ]
Kobal, Borut [1 ]
机构
[1] Univ Klin Ctr Ljubljana, Ginekol Klin, Klin Oddelek Ginekol, Ljubljana 1000, Slovenia
来源
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL | 2012年 / 81卷 / 7-8期
关键词
ovarian cancer; prognostic factors; cytoreduction; residual tumour; GYNECOLOGIC-ONCOLOGY-GROUP; SURVIVAL; SURGERY; CARCINOMA; IMPACT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Initial surgical debulking followed by a systemic chemotherapy is the standard treatment sequence for advanced ovarian cancer (AOC) treatment. The purpose of this article is to evaluate prognostic factors that impact the success of AOC treatment. Methods: All patients with AOC (FIGO stage III and IV) who were surgically treated at the Division of Gynaecology, University Medical Centre of Ljubljana, in the period from 2003 to 2008 and further received cytotoxic chemotherapy at the Institute of Oncology in Ljubljana were included in this retrospective study. Women with advanced borderline ovarian cancer and patients who initially received neoadjuvant chemotherapy and those whose adjuvant chemotherapy was not platinum-based were excluded from the analysis. Results: A total of 159 women were enrolled in the study, while data were analyzed for 116 patients. Their median age was 59 years (23-80 years) and did not have a significant influence on the treatment outcome. Clear-cell histological type of AOC was an important risk factor for a disease-free interval (DFI) (HR = 2.41, CI 95 % 0.9-5.9; p = 0.08) and overall survival (OS) (HR 4.045; 95.0% CI 1.5-10.6; p = 0.003). Post-operative residual tumour larger than 2 cm represented a statistically independent risk factor for poor OS. Residual tumour in the upper abdomen did not represent a statistically significant risk factor either for DFI (HR = 1.93; CI 95 % 0.9-4.06; p = 0.08) or for OS (HR = 1.47; 95.0 % CI 0.5-3.8; p = 0.491). Median follow up time was 29.5 months, median DFI 18 months (95 % CI 16-20) and median OS 32 months (95 % CI 22-42). 74 (63.8 %) patients died. Conclusion: Clear-cell histological type of AOC and residual tumour larger than 2 cm are the most important risk factors for early progress of the disease and poor OS. Hence improvement of surgical treatment is crucial for better treatment outcomes for patients with AOC. The latter can be achieved by an interdisciplinary surgical approach.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 50 条
  • [1] The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer
    Bachmann, Robert
    Rothmund, Ralf
    Kraemer, Bernhard
    Brucker, Sara Y.
    Koenigsrainer, Alfred
    Koenigsrainer, Ingmar
    Beckert, Stefan
    Staebler, Anette
    Phuc NguyenHuu
    Grischke, Eva
    Wallwiener, Diethelm
    Bachmann, Cornelia
    JOURNAL OF INVESTIGATIVE SURGERY, 2015, 28 (03) : 160 - 166
  • [2] Evaluation of residual tumor locations in advanced ovarian cancer patients after incomplete primary cytoreduction
    Grabowski, J. P.
    Mardas, M.
    Markowska, A.
    Markowska, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (03) : 274 - 277
  • [3] Laparoscopic Cytoreduction for Primary Advanced Ovarian Cancer
    Fanning, James
    Hojat, Rod
    Johnson, Jil
    Fenton, Bradford
    JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS, 2010, 14 (01) : 80 - 82
  • [4] Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer
    Kolev, Valentin
    Mironov, Svetlana
    Mironov, Oleg
    Ishill, Nicole
    Moskowitz, Chaya S.
    Gardner, Ginger J.
    Levine, Douglas A.
    Hricak, Hedvig
    Barakat, Richard R.
    Chi, Dennis S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (06) : 979 - 984
  • [5] The Significance of Preoperative Computed Tomography for Predicting Optimal Cytoreduction in Advanced Ovarian Cancer
    Stachs, Angrit
    Engel, Karen
    Stubert, Johannes
    Reimer, Toralf
    Gerber, Bernd
    Dieterich, Max
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (09) : 915 - 923
  • [6] Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
    Mousavi, Azam-Sadat
    Mazhari, Marjan Moradi
    Guilani, Mitra Modares
    Ghaemmaghami, Fatemeh
    Behtash, Nadereh
    Akhavan, Setareh
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2010, 8
  • [7] Prognostic Factors in Advanced Ovarian Cancer - A Clinical Trial
    Dinca, Alexandra Ligia
    Birla, Rodica Daniela
    Dinca, Valeriu Gabi
    Marica, Cristian
    Panaitescu, Eugenia
    Constantinoiu, Silviu
    CHIRURGIA, 2020, 115 (01) : 50 - 62
  • [8] Nomogram for Suboptimal Cytoreduction at Primary Surgery for Advanced Stage Ovarian Cancer
    Gerestein, Cornelis G.
    Eijkemans, Marinus J.
    Bakker, Jeanette
    Elgersma, Otto E.
    Van der Burg, Maria E. L.
    Kooi, Geertruida S.
    Burger, Curt W.
    ANTICANCER RESEARCH, 2011, 31 (11) : 4043 - 4049
  • [9] Predicting incomplete cytoreduction in patients with advanced ovarian cancer
    Egger, Eva K.
    Buchen, Marie Antonia
    Recker, Florian
    Stope, Matthias B.
    Strunk, Holger
    Mustea, Alexander
    Marinova, Milka
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Hepatobiliary Disease Resection in Patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction
    Di Donato, Violante
    Giannini, Andrea
    D'Oria, Ottavia
    Schiavi, Michele Carlo
    Di Pinto, Anna
    Fischetti, Margherita
    Lecce, Francesca
    Perniola, Giorgia
    Battaglia, Francesco
    Berloco, Pasquale
    Muzii, Ludovico
    Benedetti Panici, Pierluigi
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (01) : 222 - 230